Aktis Oncology, Inc. (AKTS)
18.90
+0.49
(+2.66%)
USD |
NASDAQ |
Feb 20, 16:00
18.54
-0.36
(-1.90%)
After-Hours: 20:00
Aktis Oncology Shareholders Equity (Quarterly) : 245.61M for Dec. 31, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Merck & Co., Inc. | -- |
| Akari Therapeutics Plc | 22.69M |
| Alumis, Inc. | 384.77M |
| Medline, Inc. | 17.14B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 331.23M |
| Total Liabilities (Quarterly) | 85.62M |